
### [MONDO:0015756](http://purl.obolibrary.org/obo/MONDO_0015756)
**Label:** myeloid hemopathy

**Subclasses:** [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0019457](http://purl.obolibrary.org/obo/MONDO_0019457) (Therapy related acute myeloid leukemia and myelodysplastic syndrome), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0019453](http://purl.obolibrary.org/obo/MONDO_0019453) (refractory cytopenia with multilineage dysplasia), [MONDO:0018881](http://purl.obolibrary.org/obo/MONDO_0018881) (myelodysplastic syndrome), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (acute myeloid leukemia), [MONDO:0017858](http://purl.obolibrary.org/obo/MONDO_0017858) (acute erythroid leukemia), [MONDO:0015688](http://purl.obolibrary.org/obo/MONDO_0015688) (myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1), [MONDO:0018874](http://purl.obolibrary.org/obo/MONDO_0018874) (acute myeloid leukemia), [MONDO:0018872](http://purl.obolibrary.org/obo/MONDO_0018872) (acute megakaryoblastic leukemia), [MONDO:0020078](http://purl.obolibrary.org/obo/MONDO_0020078) (acute myeloid leukemia with recurrent genetic anomaly), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0020311](http://purl.obolibrary.org/obo/MONDO_0020311) (chronic myelomonocytic leukemia), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0019460](http://purl.obolibrary.org/obo/MONDO_0019460) (acute leukemia of ambiguous lineage), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0020077](http://purl.obolibrary.org/obo/MONDO_0020077) (myelodysplastic/myeloproliferative disease), [MONDO:0015667](http://purl.obolibrary.org/obo/MONDO_0015667) (unclassified acute myeloid leukemia), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:86836](http://www.orpha.net/ORDO/Orphanet_86836), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:86851](http://www.orpha.net/ORDO/Orphanet_86851), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [Orphanet:518](http://www.orpha.net/ORDO/Orphanet_518), [Orphanet:168943](http://www.orpha.net/ORDO/Orphanet_168943), [Orphanet:167714](http://www.orpha.net/ORDO/Orphanet_167714), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [Orphanet:318](http://www.orpha.net/ORDO/Orphanet_318), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [Orphanet:98275](http://www.orpha.net/ORDO/Orphanet_98275), [Orphanet:98277](http://www.orpha.net/ORDO/Orphanet_98277), [OMIM:300331](http://purl.obolibrary.org/obo/OMIM_300331), [OMIM:133180](http://purl.obolibrary.org/obo/OMIM_133180), [Orphanet:86846](http://www.orpha.net/ORDO/Orphanet_86846), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:131440](http://purl.obolibrary.org/obo/OMIM_131440), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:98823](http://www.orpha.net/ORDO/Orphanet_98823), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), 

**Class expressions from DL-Learner:**

- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 46.56%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 45.59%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding))) 40.64%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000024](http://purl.obolibrary.org/obo/HP_0000024) (Prostatitis))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000023](http://purl.obolibrary.org/obo/HP_0000023) (Inguinal hernia))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 39.94%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 39.94%


